Lipidomics studies on macrophages - RAW 264.7 cells treated with Kdo2-Lipid A and compactin

Introduction | Browse | Search | Download
Mouse-over the above links for more information

Treatment details

LM ID Analyte Treatment Time(hrs) Sample ID Value Units
LMFA01050145 13-HOTrE(y) cPLA2i 1.0 BCD110605C28 0.089 pmol/ml medium
LMFA01050145 13-HOTrE(y) cPLA2i 1.0 BCD110605C30 0.122 pmol/ml medium
LMFA01050145 13-HOTrE(y) cPLA2i 1.0 BCD110605C29 0.113 pmol/ml medium
LMFA01050145 13-HOTrE(y) cPLA2i 20.0 BCD110605C64 0.232 pmol/ml medium
LMFA01050145 13-HOTrE(y) cPLA2i 20.0 BCD110605C66 0.237 pmol/ml medium
LMFA01050145 13-HOTrE(y) cPLA2i 20.0 BCD110605C65 0.21 pmol/ml medium
LMFA01050145 13-HOTrE(y) PLDi 1.0 BCD110605C16 0.125 pmol/ml medium
LMFA01050145 13-HOTrE(y) PLDi 1.0 BCD110605C17 0.114 pmol/ml medium
LMFA01050145 13-HOTrE(y) PLDi 1.0 BCD110605C18 0.093 pmol/ml medium
LMFA01050145 13-HOTrE(y) PLDi 20.0 BCD110605C54 0.25 pmol/ml medium
LMFA01050145 13-HOTrE(y) PLDi 20.0 BCD110605C52 0.265 pmol/ml medium
LMFA01050145 13-HOTrE(y) PLDi 20.0 BCD110605C53 0.311 pmol/ml medium
LMFA01050145 13-HOTrE(y) KDO+cPLA2i 1.0 BCD110605C32 0.121 pmol/ml medium
LMFA01050145 13-HOTrE(y) KDO+cPLA2i 1.0 BCD110605C31 0.121 pmol/ml medium
LMFA01050145 13-HOTrE(y) KDO+cPLA2i 1.0 BCD110605C33 0.126 pmol/ml medium
LMFA01050145 13-HOTrE(y) KDO+cPLA2i 20.0 BCD110605C68 0.282 pmol/ml medium
LMFA01050145 13-HOTrE(y) KDO+cPLA2i 20.0 BCD110605C69 0.276 pmol/ml medium
LMFA01050145 13-HOTrE(y) KDO+cPLA2i 20.0 BCD110605C67 0.276 pmol/ml medium
LMFA01050145 13-HOTrE(y) KDO+PLDi 1.0 BCD110605C19 0.114 pmol/ml medium
LMFA01050145 13-HOTrE(y) KDO+PLDi 1.0 BCD110605C20 0.108 pmol/ml medium
LMFA01050145 13-HOTrE(y) KDO+PLDi 1.0 BCD110605C21 0.097 pmol/ml medium
LMFA01050145 13-HOTrE(y) KDO+PLDi 20.0 BCD110605C56 0.374 pmol/ml medium
LMFA01050145 13-HOTrE(y) KDO+PLDi 20.0 BCD110605C57 0.325 pmol/ml medium
LMFA01050145 13-HOTrE(y) KDO+PLDi 20.0 BCD110605C55 0.324 pmol/ml medium
LMFA01050145 13-HOTrE(y) KDO+ATP+cPLA2i 1.0 BCD110605C37 0.116 pmol/ml medium
LMFA01050145 13-HOTrE(y) KDO+ATP+cPLA2i 1.0 BCD110605C38 0.114 pmol/ml medium
LMFA01050145 13-HOTrE(y) KDO+ATP+cPLA2i 1.0 BCD110605C39 0.098 pmol/ml medium
LMFA01050145 13-HOTrE(y) KDO+ATP+cPLA2i 20.0 BCD110605C74 0.267 pmol/ml medium
LMFA01050145 13-HOTrE(y) KDO+ATP+cPLA2i 20.0 BCD110605C75 0.221 pmol/ml medium
LMFA01050145 13-HOTrE(y) KDO+ATP+cPLA2i 20.0 BCD110605C73 0.223 pmol/ml medium
LMFA01050145 13-HOTrE(y) KDO+ATP+PLDi 1.0 BCD110605C25 0.099 pmol/ml medium
LMFA01050145 13-HOTrE(y) KDO+ATP+PLDi 1.0 BCD110605C27 0.091 pmol/ml medium
LMFA01050145 13-HOTrE(y) KDO+ATP+PLDi 1.0 BCD110605C26 0.104 pmol/ml medium
LMFA01050145 13-HOTrE(y) KDO+ATP+PLDi 20.0 BCD110605C61 0.259 pmol/ml medium
LMFA01050145 13-HOTrE(y) KDO+ATP+PLDi 20.0 BCD110605C62 0.259 pmol/ml medium
LMFA01050145 13-HOTrE(y) KDO+ATP+PLDi 20.0 BCD110605C63 0.269 pmol/ml medium
LMFA01050145 13-HOTrE(y) KDO + ATP 1.0 BCD110605C15 0.08 pmol/ml medium
LMFA01050145 13-HOTrE(y) KDO + ATP 1.0 BCD110605C14 0.094 pmol/ml medium
LMFA01050145 13-HOTrE(y) KDO + ATP 1.0 BCD110605C13 0.09 pmol/ml medium
LMFA01050145 13-HOTrE(y) KDO + ATP 20.0 BCD110605C49 0.332 pmol/ml medium
LMFA01050145 13-HOTrE(y) KDO + ATP 20.0 BCD110605C50 0.292 pmol/ml medium
LMFA01050145 13-HOTrE(y) KDO + ATP 20.0 BCD110605C51 0.282 pmol/ml medium
LMFA01050145 13-HOTrE(y) KDO 1.0 BCD110605C08 0.104 pmol/ml medium
LMFA01050145 13-HOTrE(y) KDO 1.0 BCD110605C07 0.116 pmol/ml medium
LMFA01050145 13-HOTrE(y) KDO 1.0 BCD110605C09 0.088 pmol/ml medium
LMFA01050145 13-HOTrE(y) KDO 20.0 BCD110605C45 0.296 pmol/ml medium
LMFA01050145 13-HOTrE(y) KDO 20.0 BCD110605C44 0.357 pmol/ml medium
LMFA01050145 13-HOTrE(y) KDO 20.0 BCD110605C43 0.319 pmol/ml medium
LMFA01050145 13-HOTrE(y) C 0.0 BCD110605C03 0.135 pmol/ml medium
LMFA01050145 13-HOTrE(y) C 0.0 BCD110605C01 0.085 pmol/ml medium